Oct 222014
 

oabutton_logo_final200Open Access Button press release, Link, CC-BY
Joseph McArthur, +447732634892 | media@openaccessbutton.org

London, England. The Open Access Button today launched a suite of new apps to help researchers, patients, students and the public get access to scientific and scholarly research. People use research everyday to create scientific and medical advances, understand culture, and fuel the economy, but articles can cost $30 or more to read each, even though much of the research is funded by the public in the first place. The new apps are available both for mobile phones and web browsers and can be downloaded at openaccessbutton.org.  Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Sep 052014
 

ecuador flagIssues New Compulsory Licenses; Signs Harmful Trade Agreement with the EU

[Luz Marina Umbasia and Peter Maybarduk, Link to PDF]  In July, Ecuador issued four compulsory licenses for medicines targeting cancer and arthritis treatment and immunological reception to kidney transplant.[1] These licenses authorize cost-cutting generic competition with patented medicines, in exchange for royalty payments to the patent holders. Compulsory licensing is a crucial tool to expand access to medicines that are prohibitively expensive or whose costs place enormous burdens on budgets for health systems.[2] Ecuador has again demonstrated international leadership by exercising its health rights. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Sep 022014
 

ncube[Reposted from Aro-IP, Link (CC-BY)]  Moneyweb is suing Fin24 for copyright infringement arising out of Fin24’s (re-)publication of eight articles which had been initially published by Moneyweb (see a Mail and Guardian report here). Moneyweb has created a dedicated website (here) where it has posted all of the pleadings filed to date and media articles. This Leo rarely has an opportunity to read litigants’ court documents and is delighted that these documents are so readily available. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Jul 242014
 

cc[Cross posted from CCUSA, Link (CC-BY)]  Today, Creative Commons and Creative Commons U.S.A. are sending a letter to Secretary of Education Arne Duncan supporting the Department of Education’s (DOE) adoption of the Hewlett Foundation’s definition of Open Educational Resources, and asking the Department to require open licenses for works funded by its grants. 

The full letter is available here.  An excerpt follows: Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Jul 212014
 

tac-logo[Lotti Rutter, Treatment Action Campaign, Link (CC-BY)]  In 2011, the UN and member states set a goal of reaching 15 million people on AIDS treatment by 2015—a goal many questioned but that will be met next year. Since then, evidence and tools available have changed and it is clear that simply tracking testing and treatment is not good enough.  Critically, it is now clear that suppressing the HIV virus with high-quality HIV drugs keeps people living with HIV alive and healthy while also preventing HIV transmission. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Jul 172014
 

euro open edu policy project logo[Cross posted from the European Open Edu Policy Project, Link (CC-BY)]  It is well known that the rules that allow for certain educational uses of copyrighted works under certain conditions without permission of the rights’ owners vary greatly between countries. But how different are those rules? And how difficult is to access those differences? Can a teacher with no legal background determine alone whether a certain use is allowed or not in his/her country? Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Jul 152014
 
Photo by Ito (CC-BY-2.0)

Photo by Ito (CC-BY-2.0)

[Cross posted from Creative Commons-USA, Link, (CC-BY)]  Chairman Coble, Ranking Member Nadler, Chairman Goodlatte, Ranking Member Conyers, and members of the Subcommittee, my name is Michael Carroll, and I am a member of the faculty at American University Washington College of Law, where I direct the Program on Information Justice and Intellectual Property and serve as the Public Lead for Creative Commons USA.  Creative Commons USA is the United States’ project that works under the terms of an agreement with Creative Commons, Inc., a global non-profit corporation headquartered in California.  Creative Commons has agreements with projects in more than 70 countries through which the local project is authorized to represent Creative Commons at the national level.  Creative Commons and Creative Commons USA have some experiences and legal tools that are relevant to the topics of today’s hearing.  Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Jun 182014
 

medicines patent poolThe Pediatric HIV Treatment Initiative was launched today at an event on Capitol Hill. The initiative plans to foster the development, manufacture, and distribution of pediatric formulations of antiretroviral therapies for the treatment of HIV/AIDS. It will draw on the Medicines Patent Pool’s existing relationships to obtain the necessary intellectual property rights and production know-how from branded firms, and transfer the technology to generic firms. It then plans to coordinate large-scale purchases to ensure the medicines get to children in need. The Pediatric HIV Treatment Initiative is a joint project of the Medicines Patent Pool, the Drugs for Neglected Diseases Initiative, and UNITAID. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Jun 102014
 

lca[Library Copyright Alliance Press Release, Link] The Library Copyright Alliance is extremely pleased with today’s decision by the US Court of Appeals for the Second Circuit in Authors Guild v. HathiTrust, finding in favor of fair use. The Library Copyright Alliance filed an amicus brief (PDF) in the case, supporting HathiTrust’s position and the lower court’s finding of fair use. Jonathan Band, counsel for the Library Copyright Alliance, said, “The decision is a significant victory for the public.” Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
May 192014
 

opn[Timothy Vollmer, Open Policy Network, Link, (CC-BY)]  Today we’re excited to announce the launch of the Open Policy Network. The Open Policy Network, or OPN for short, is a coalition of organizations and individuals working to support the creation, adoption, and implementation of policies that require that publicly funded resources are openly licensed resources. The website of the Open Policy Network is http://openpolicynetwork.org Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly
Apr 172014
 

peru flagPharmaceutical companies’ abuse of monopolistic position results in million-dollar overspending in public purchases.

[Javier Llamoza and Ana Romero] Atazanavir is an antiretroviral, second-line medicine that is used to treat people living with HIV.   In Peru, this drug is patented by Bristol Myers Squibb (BMS), ensuring exclusivity and a high price for the same in the national market.  A related result of this situation is that Peru’s public health sector overspends approximately US$ 7.5 million annually, as the present patent on Atazanavir does not allow for the purchase of the generic product.   In contrast, the generic version of this medicine is available in Bolivia, for example, and costs that country US$ 0.50 per 300mg tablet, while in  Peru, an average of  US$ 12.85 is paid for the original brand name (Reyataz tab 300mg ),  24 times more for the same product. Continue reading »

FacebookTwitterRedditStumbleUponWordPressTumblrBlogger PostEmailPrintFriendly